Spontaneous bacterial peritonitis and pneumonia caused by Bordetella bronchiseptica

Bordetella bronchiseptica is a rare cause of invasive human infection. The most common infection in humans is the respiratory tract infection and it is usually associated with immunosuppression, particularly acquired immunodeficiency syndrome (AIDS). We report a case of a pneumonia and peritonitis in a 42-year-old female with alcoholic liver disease. The patient died despite treatment with antibiotics. This case illustrates the potential virulence of B. bronchiseptica in susceptible patients and to our knowledge it is the first case of primary peritonitis due to this organism.

Download Full-text

Specific Antibody Immunodeficiency Presenting With Streptococcal pneumonia-Induced Spontaneous Bacterial Peritonitis

Allergy & Rhinology ◽

10.1177/2152656720928065 ◽

2020 ◽

Vol 11 ◽

pp. 215265672092806

Author(s):

Jack Jeskey ◽

Akash Parida ◽

Kelsey Graven ◽

Robert Hostoffer

Keyword(s):

Specific Antibody ◽

Spontaneous Bacterial Peritonitis ◽

Respiratory Infections ◽

Recurrent Infections ◽

Primary Immunodeficiency Disorder ◽

Bacterial Peritonitis ◽

First Case ◽

Immunodeficiency Disorder ◽

Insufficient Response ◽

Acquired Immunodeficiency

Specific antibody immunodeficiency (SAD) is a primary immunodeficiency disorder characterized by normal levels of serum immunoglobulins (IgG, IgA, and IgM) associated with a dysfunctional immune response. SAD is associated with recurrent infections in the setting of an insufficient response to polysaccharide vaccinations. Streptococcus pneumoniae is a well-established cause of respiratory infections in SAD. However, there has been a paucity of evidence of pneumococcal peritonitis in SAD patients, being reported as spontaneous in acquired immunodeficiency such as AIDS. We report the first case of S. pneumoniae-induced peritonitis as the presenting sign for SAD.

Download Full-text

Plasmablastic Lymphoma of the Lung

Archives of Pathology & Laboratory Medicine ◽

10.5858/2001-125-0282-plotl ◽

2001 ◽

Vol 125 (2) ◽

pp. 282-285 ◽

Cited By ~ 8

Author(s):

Yuan Lin ◽

Gilberto D. Rodrigues ◽

John F. Turner ◽

Mohammad A. Vasef

Keyword(s):

Hodgkin Lymphoma ◽

Acquired Immunodeficiency Syndrome ◽

Lung Tumor ◽

B Cell Lymphoma ◽

Plasmablastic Lymphoma ◽

Non Hodgkin Lymphoma ◽

First Case ◽

Acquired Immunodeficiency ◽

Immunodeficiency Syndrome ◽

Distinct Subtype

Abstract Non-Hodgkin lymphomas associated with acquired immunodeficiency syndrome are heterogeneous. Recently, a novel subtype of non-Hodgkin lymphoma occurring mostly in patients with acquired immunodeficiency syndrome has been described and designated as plasmablastic lymphoma. The histomorphologic and immunophenotypic findings of this distinct subtype of non-Hodgkin lymphoma have been characterized previously. Most patients present with oral cavity involvement. We report a case of plasmablastic lymphoma presenting as a lung tumor. To our knowledge, this is the first case report of this unusual subtype of diffuse large B-cell lymphoma in this location.

Download Full-text

Changing causes of death in Pennsylvania's hemophiliacs 1976 to 1991: impact of liver disease and acquired immunodeficiency syndrome [letter]

Blood ◽

10.1182/blood.v79.9.2494.2494 ◽

1992 ◽

Vol 79 (9) ◽

pp. 2494-2495 ◽

Cited By ~ 18

Author(s):

ME Eyster ◽

JH Schaefer ◽

MV Ragni ◽

TJ Gorenc ◽

S Shapiro ◽

...

Keyword(s):

Liver Disease ◽

Acquired Immunodeficiency Syndrome ◽

Causes Of Death ◽

Acquired Immunodeficiency ◽

Immunodeficiency Syndrome

Download Full-text

The First Case of Vestibulocochlear Neuritis in a Patient with Acquired Immunodeficiency Syndrome in Korea

Infection and Chemotherapy ◽

10.3947/ic.2016.48.2.132 ◽

2016 ◽

Vol 48 (2) ◽

pp. 132

Author(s):

Hyun Joo Park ◽

Chin Saeng Cho ◽

Nak Min Kim ◽

Su A Yun ◽

Hee Jung Yoon

Keyword(s):

Acquired Immunodeficiency Syndrome ◽

First Case ◽

Acquired Immunodeficiency ◽

Immunodeficiency Syndrome

Download Full-text

Leptospirosis patient with AIDS the first case reported

Revista da Sociedade Brasileira de Medicina Tropical ◽

10.1590/s0037-86821994000100008 ◽

1994 ◽

Vol 27 (1) ◽

pp. 39-42 ◽

Cited By ~ 8

Author(s):

Elizabeth de Souza Neves ◽

Martha Maria Pereira ◽

Maria Clara Gutierrez Galhardo ◽

Adriana Caroli ◽

Jarbas Andrade ◽

...

Keyword(s):

Clinical Course ◽

Blood Cultures ◽

Agglutination Test ◽

Leptospira Interrogans ◽

First Case ◽

Positive Urine ◽

Maximum Titer ◽

Acquired Immunodeficiency ◽

Low Levels ◽

Immunodeficiency Syndrome

A case of renal icterohaemorrhagic leptospirosis involving a patient with acquired immunodeficiency syndrome (AIDS) is reported. Despite the low levels of CD4+ Tlymphocytes, the clinical course of leptospirosis was similar to that observed in non-immunodepressed patients, and no worsening of AIDS occurred due to the infebtion by the spirochete. Serologic conversion was observed in the microscopic agglutination test, with maximum titer of1:3,200. The patient had positive urine cultures for Leptospira interrogans for two months, whereas blood cultures were negative.

Download Full-text

Pyrroles as Privileged Scaffolds in the Search for New Potential HIV Inhibitors

Pharmaceuticals ◽

10.3390/ph14090893 ◽

2021 ◽

Vol 14 (9) ◽

pp. 893

Author(s):

Maria da Conceição Avelino Dias Bianco ◽

Debora Inacio Leite Firmino Marinho ◽

Lucas Villas Boas Hoelz ◽

Monica Macedo Bastos ◽

Nubia Boechat

Keyword(s):

New Drugs ◽

Viral Load Suppression ◽

Pyrrole Derivatives ◽

Highly Active ◽

First Case ◽

Combined Antiretroviral Therapy ◽

Acquired Immunodeficiency ◽

Immunodeficiency Syndrome ◽

Anti Hiv Agents ◽

Anti Hiv

Acquired immunodeficiency syndrome (AIDS) is caused by human immunodeficiency virus (HIV) and remains a global health problem four decades after the report of its first case. Despite success in viral load suppression and the increase in patient survival due to combined antiretroviral therapy (cART), the development of new drugs has become imperative due to strains that have become resistant to antiretrovirals. In this context, there has been a continuous search for new anti-HIV agents based on several chemical scaffolds, including nitrogenated heterocyclic pyrrole rings, which have been included in several compounds with antiretroviral activity. Thus, this review aims to describe pyrrole-based compounds with anti-HIV activity as a new potential treatment against AIDS, covering the period between 2015 and 2020. Our research allowed us to conclude that pyrrole derivatives are still worth exploring, as they may provide highly active compounds targeting different steps of the HIV-1 replication cycle and act with an innovative mechanism.

Download Full-text